RXL

Ultra Health Care

Investment Objective

ProShares Ultra Health Care seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P Health Care Select SectorSM Index.

Documents & Downloads

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
RXL Market Price -4.69% 10.70% -12.64% 10.70% -7.51% -1.15% 16.92% 11.07% 14.95% 01/30/2007
RXL NAV -3.97% 11.47% -11.99% 11.47% -6.65% -0.81% 17.19% 11.22% 15.00% 01/30/2007

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    RXL
  • Intraday Ticker
    RXL.IV
  • CUSIP
    74347R735
  • Inception Date
    1/30/07
  • Gross Expense Ratio
    1.05%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/24/2025
  • NAV
    $42.84
  • NAV Change
    $+1.03 up caret
  • Market Price
    $42.89
  • Market Price Change
    $+1.03 up caret
  • Trading Volume (M)
    14,389
  • View Premium / Discount
Snapshot
  • Ticker
    RXL
  • Intraday Ticker
    RXL.IV
  • CUSIP
    74347R735
  • Inception Date
    1/30/07
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    1.05%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/24/2025
  • NAV
    $42.84
  • NAV Change
    $+1.03 up caret
  • Market Price
    $42.89
  • Market Price Change
    $+1.03 up caret
  • Trading Volume (M)
    14,389
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.

Exposures

Index as of 3/31/2025

Holdings

as of 4/24/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
10.41% LLY ELI LILLY & CO -- $7,493,406.68 8,716 2516152
6.00% UNH UNITEDHEALTH GROUP INC -- $4,319,289.25 10,181 2917766
5.73% JNJ JOHNSON & JOHNSON -- $4,126,405.62 26,634 2475833
4.89% ABBV ABBVIE INC -- $3,522,626.10 19,530 B92SR70
3.45% ABT ABBOTT LABORATORIES -- $2,482,543.44 19,188 2002305
3.10% MRK MERCK & CO. INC. -- $2,233,044.96 27,969 2778844
2.79% ISRG INTUITIVE SURGICAL INC -- $2,004,572.85 3,945 2871301
2.51% TMO THERMO FISHER SCIENTIFIC INC -- $1,805,625.12 4,232 2886907
2.31% AMGN AMGEN INC -- $1,662,809.28 5,942 2023607
2.29% BSX BOSTON SCIENTIFIC CORP -- $1,648,683.14 16,301 2113434
2.03% GILD GILEAD SCIENCES INC -- $1,463,490.05 13,787 2369174
1.98% PFE PFIZER INC -- $1,428,123.76 62,692 2684703
1.94% VRTX VERTEX PHARMACEUTICALS INC -- $1,399,107.27 2,841 2931034
1.93% DHR DANAHER CORP -- $1,391,416.50 7,081 2250870
1.91% SYK STRYKER CORP -- $1,371,267.90 3,798 2853688
1.66% MDT MEDTRONIC PLC -- $1,195,795.50 14,185 BTN1Y11
1.53% ELV ELEVANCE HEALTH INC -- $1,100,703.93 2,567 BSPHGL4
1.52% BMY BRISTOL-MYERS SQUIBB CO -- $1,093,090.50 22,450 2126335
1.41% CI THE CIGNA GROUP -- $1,016,835.30 3,029 BHJ0775
1.33% MCK MCKESSON CORP -- $954,852.41 1,387 2378534
1.28% CVS CVS HEALTH CORP -- $918,858.88 13,939 2577609
1.05% ZTS ZOETIS INC -- $754,646.50 4,955 B95WG16
0.97% REGN REGENERON PHARMACEUTICALS -- $697,520.88 1,163 2730190
0.94% HCA HCA HEALTHCARE INC -- $674,967.57 1,977 B4MGBG6
0.90% BDX BECTON DICKINSON AND CO -- $649,333.20 3,176 2087807
0.75% COR CENCORA INC -- $539,364.90 1,910 2795393
0.68% EW EDWARDS LIFESCIENCES CORP -- $490,223.25 6,525 2567116
0.55% IDXX IDEXX LABORATORIES INC -- $399,086.90 905 2459202
0.53% RMD RESMED INC -- $383,426.40 1,624 2732903
0.50% CAH CARDINAL HEALTH INC -- $363,100.32 2,673 2175672
0.50% HUM HUMANA INC -- $357,285.22 1,334 2445063
0.47% GEHC GE HEALTHCARE TECHNOLOGY -- $339,424.80 5,060 BL6JPG8
0.47% CNC CENTENE CORP -- $337,889.46 5,487 2807061
0.47% A AGILENT TECHNOLOGIES INC -- $337,755.12 3,156 2520153
0.43% DXCM DEXCOM INC -- $305,911.16 4,322 B0796X4
0.39% IQV IQVIA HOLDINGS INC -- $278,908.68 1,851 BDR73G1
0.35% MTD METTLER-TOLEDO INTERNATIONAL -- $248,325.00 231 2126249
0.34% STE STERIS PLC -- $246,042.45 1,087 BFY8C75
0.31% WAT WATERS CORP -- $223,839.90 657 2937689
0.31% ZBH ZIMMER BIOMET HOLDINGS INC -- $223,503.00 2,202 2783815
0.30% DGX QUEST DIAGNOSTICS INC -- $216,320.10 1,230 2702791
0.29% LH LABCORP HOLDINGS INC -- $210,750.76 922 BSBK800
0.28% PODD INSULET CORP -- $201,278.88 776 B1XGNW4
0.27% BIIB BIOGEN INC -- $193,486.69 1,619 2455965
0.27% MOH MOLINA HEALTHCARE INC -- $192,365.53 613 2212706
0.25% COO COOPER COS INC/THE -- $182,336.64 2,208 BQPDXR3
0.24% BAX BAXTER INTERNATIONAL INC -- $171,755.68 5,648 2085102
0.23% WST WEST PHARMACEUTICAL SERVICES -- $168,682.59 801 2950482
0.20% HOLX HOLOGIC INC -- $144,675.78 2,482 2433530
0.20% ALGN ALIGN TECHNOLOGY INC -- $143,177.79 777 2679204
0.18% RVTY REVVITY INC -- $128,140.11 1,347 2305844
0.16% UHS UNIVERSAL HEALTH SERVICES-B -- $113,100.00 650 2923785
0.15% VTRS VIATRIS INC -- $106,028.12 13,204 BMWS3X9
0.15% INCY INCYTE CORP -- $104,848.66 1,778 2471950
0.14% SOLV SOLVENTUM CORP -- $103,185.84 1,528 BMTQB43
0.14% MRNA MODERNA INC -- $102,630.33 3,747 BGSXTS3
0.13% HSIC HENRY SCHEIN INC -- $91,397.40 1,380 2416962
0.12% TECH BIO-TECHNE CORP -- $88,814.22 1,749 BSHZ3Q0
0.09% DVA DAVITA INC -- $67,826.16 486 2898087
0.09% CRL CHARLES RIVER LABORATORIES -- $65,520.16 566 2604336
38.63% -- HEALTH CARE SELECT SECTOR INDEX SWAP UBS AG 27,802,012 -- 20,032 --
23.58% -- HEALTH CARE SELECT SECTOR INDEX SWAP BANK OF AMERICA NA 16,969,609 -- 12,227 --
20.87% -- HEALTH CARE SELECT SECTOR INDEX SWAP GOLDMAN SACHS INTERNATIONAL 15,018,249 -- 10,821 --
15.39% -- HEALTH CARE SELECT SECTOR INDEX SWAP CITIBANK NA 11,078,058 -- 7,982 --
12.85% -- HEALTH CARE SELECT SECTOR INDEX SWAP SOCIETE GENERALE 9,246,057 -- 6,662 --
11.56% -- HEALTH CARE SELECT SECTOR INDEX SWAP BNP PARIBAS 8,319,508 -- 5,994 --
-- -- TREASURY BILL -- $6,966,387.12 7,000,000 BN7T6L3
-- -- TREASURY BILL -- $5,977,714.68 6,000,000 BQC9631
-- -- TREASURY BILL -- $2,981,427.93 3,000,000 BSNQ2D7
-- -- NET OTHER ASSETS (LIABILITIES) -- $763,411.85 763,412 --

Index

as of 3/31/2025

  • Total Number of Companies60
  • Price/Earnings Ratio22.241
  • Price/Book Ratio5.143
  • Dividend Yield ( % )1.56
  • Avg. Index Market Capitalization$92.03 billion
About the Index

The S&P Health Care Select Sector Index is designed to measure the performance of health care companies included in the S&P 500 Index.

The Index includes health care companies in the following industries according to the Global Industry Classification Standard (GICS): health care equipment & supplies, health care providers & services; health care technology; biotechnology; pharmaceuticals; and life sciences tools & services.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.